These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 16565714)

  • 1. Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization.
    Bosco DA; Fowler DM; Zhang Q; Nieva J; Powers ET; Wentworth P; Lerner RA; Kelly JW
    Nat Chem Biol; 2006 May; 2(5):249-53. PubMed ID: 16565714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of protein nitration in dementia with Lewy bodies and striatonigral degeneration.
    Gómez-Tortosa E; Gonzalo I; Newell K; García Yébenes J; Vonsattel P; Hyman BT
    Acta Neuropathol; 2002 May; 103(5):495-500. PubMed ID: 11935266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice.
    Schell H; Hasegawa T; Neumann M; Kahle PJ
    Neuroscience; 2009 Jun; 160(4):796-804. PubMed ID: 19272424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies.
    Klucken J; Ingelsson M; Shin Y; Irizarry MC; Hedley-Whyte ET; Frosch M; Growdon J; McLean P; Hyman BT
    Acta Neuropathol; 2006 Feb; 111(2):101-8. PubMed ID: 16482476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecule oxidation products trigger disease-associated protein misfolding.
    Bieschke J; Zhang Q; Bosco DA; Lerner RA; Powers ET; Wentworth P; Kelly JW
    Acc Chem Res; 2006 Sep; 39(9):611-9. PubMed ID: 16981677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro characterisation of BF227 binding to alpha-synuclein/Lewy bodies.
    Fodero-Tavoletti MT; Mulligan RS; Okamura N; Furumoto S; Rowe CC; Kudo Y; Masters CL; Cappai R; Yanai K; Villemagne VL
    Eur J Pharmacol; 2009 Sep; 617(1-3):54-8. PubMed ID: 19576880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gelsolin co-occurs with Lewy bodies in vivo and accelerates α-synuclein aggregation in vitro.
    Welander H; Bontha SV; Näsström T; Karlsson M; Nikolajeff F; Danzer K; Kostka M; Kalimo H; Lannfelt L; Ingelsson M; Bergström J
    Biochem Biophys Res Commun; 2011 Aug; 412(1):32-8. PubMed ID: 21798243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early alpha-synuclein lipoxidation in neocortex in Lewy body diseases.
    Dalfó E; Ferrer I
    Neurobiol Aging; 2008 Mar; 29(3):408-17. PubMed ID: 17166629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low alpha-synuclein 126 mRNA levels in dementia with Lewy bodies and Alzheimer disease.
    Beyer K; Humbert J; Ferrer A; Lao JI; Carrato C; López D; Ferrer I; Ariza A
    Neuroreport; 2006 Aug; 17(12):1327-30. PubMed ID: 16951579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-aggregation and fibril-destabilizing effects of sex hormones on alpha-synuclein fibrils in vitro.
    Hirohata M; Ono K; Morinaga A; Ikeda T; Yamada M
    Exp Neurol; 2009 Jun; 217(2):434-9. PubMed ID: 19289119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of dopamine-mediated alpha-synuclein-soluble oligomers requires methionine oxidation.
    Leong SL; Pham CL; Galatis D; Fodero-Tavoletti MT; Perez K; Hill AF; Masters CL; Ali FE; Barnham KJ; Cappai R
    Free Radic Biol Med; 2009 May; 46(10):1328-37. PubMed ID: 19248830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end products induce in vitro cross-linking of alpha-synuclein and accelerate the process of intracellular inclusion body formation.
    Shaikh S; Nicholson LF
    J Neurosci Res; 2008 Jul; 86(9):2071-82. PubMed ID: 18335520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of alpha-synuclein isoforms in dementia with Lewy bodies.
    Beyer K; Lao JI; Carrato C; Mate JL; López D; Ferrer I; Ariza A
    Neuropathol Appl Neurobiol; 2004 Dec; 30(6):601-7. PubMed ID: 15541000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intralaminar nuclei of the thalamus in Lewy body diseases.
    Brooks D; Halliday GM
    Brain Res Bull; 2009 Feb; 78(2-3):97-104. PubMed ID: 18804518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases.
    Duda JE; Giasson BI; Mabon ME; Lee VM; Trojanowski JQ
    Ann Neurol; 2002 Aug; 52(2):205-10. PubMed ID: 12210791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress induces nuclear translocation of C-terminus of alpha-synuclein in dopaminergic cells.
    Xu S; Zhou M; Yu S; Cai Y; Zhang A; Uéda K; Chan P
    Biochem Biophys Res Commun; 2006 Mar; 342(1):330-5. PubMed ID: 16480958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies.
    Obi K; Akiyama H; Kondo H; Shimomura Y; Hasegawa M; Iwatsubo T; Mizuno Y; Mochizuki H
    Exp Neurol; 2008 Apr; 210(2):409-20. PubMed ID: 18164295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective detection, quantification, and subcellular location of alpha-synuclein aggregates with a protein aggregate filtration assay.
    Kramer ML; Behrens C; Schulz-Schaeffer WJ
    Biotechniques; 2008 Mar; 44(3):403-11. PubMed ID: 18361794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of Parkinson's disease: a case for the selective vulnerability of the substantia nigra.
    Galvin JE
    Acta Neuropathol; 2006 Aug; 112(2):115-26. PubMed ID: 16791599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.